Skip to main content

Nasdaq News

CAC 40 Off Day's Highs

6 years 6 months ago
(RTTNews) - French stocks opened higher on Tuesday as a flattening of the coronavirus curve pointed to the slowing of the spread of the disease globally and solid trade data from China helped ease fears of a deep global recession.

Hong Kong shares end higher as China trade data lifts sentiment

6 years 6 months ago
Hong Kong shares closed higher on Tuesday after China reported smaller-than-expected contractions in imports and exports in March, and as fears over the global spread of the new coronavirus eased. ** The Hang Seng index ended up 135.07 points or 0.56% at 24,435.40. The Hang Seng China Enterprises index rose 0.37% to 9,847.47. ** The sub-index of the Hang Seng tracking energy shares dipped 1.1%, while the IT sector rose 1.12%, the financial sector ended 0.6% higher and the property sector rose 1.05%. ** China's exports fell 6.6% in March from a year earlier, while imports shrank 0.9%, a better-than-expected outcome as factories restarted production, though the global coronavirus health crisis looks set to keep trade under pressure over coming months. [nB9N2BR00K] ** The top gainer on the Hang Seng was CK Asset Holdings Ltd, which gained 3.76%, while the biggest loser was AAC Technologies Holdings Inc, which fell 3.21%. ** China's main Shanghai Composite index closed up 1.59% at 2,827.28, while the blue-chip CSI300 index ended up 1.93%. ** Around the region, MSCI's Asia ex-Japan stock index was firmer by 1.28%, while Japan's Nikkei index closed up 3.13%. ** The yuan was quoted at 7.0583 per U.S. dollar at 0825 GMT, 0.08% weaker than the previous close of 7.053. ** The top gainers among H-shares were BYD Co Ltd up 3.33%, followed by CITIC Securities Co Ltd, gaining 3.31% and China Conch Venture Holdings Ltd, up by 3%. ** The three biggest H-shares percentage decliners were CNOOC Ltd, which was down 2.69%, PetroChina Co Ltd, which fell 2.68% and Sunny Optical Technology Group Co Ltd, down by 2.31%. (Reporting by Andrew Galbraith; editing by Uttaresh.V) ((Andrew.Galbraith@tr.com; +86 21 2083 0079; Reuters Messaging: andrew.galbraith.thomsonreuters.com@reuters.net ; Twitter: https://twitter.com/apgalbraith)) nAZN18NU00

AstraZeneca to start Calquence in COVID-19 trial

6 years 6 months ago
AstraZeneca Plc said on Tuesday that it would start a clinical trial to assess the potential of Calquence in the treatment of the exaggerated immune response associated with COVID-19 infection in severely ill patients.

AstraZeneca to start Calquence in COVID-19 trial

6 years 6 months ago
AstraZeneca Plc said on Tuesday that it would start a clinical trial to assess the potential of Calquence in the treatment of the exaggerated immune response associated with COVID-19 infection in severely ill patients.
Checked
7 minutes 5 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed